Utility of IMWG Frailty Scoring in Patients With Relapsed/Refractory Multiple Myeloma
While the International Myeloma Working Group (IMWG) Index was validated in scoring patients with newly diagnosed multiple myeloma, its relevance for patients with relapsed or refractory multiple myeloma was uncertain. Therefore, Fabio Efficace, PhD, and a team of researchers investigated IMWG frailty scoring in patients with previously treated disease. Their study, presented at the 2021 American Society of Hematology Annual Meeting and Exposition, reported that the IMWG was able to identify distinct patient-reported health-related quality of life (HRQOL) profiles in relapsed/refractory disease, as well. ...
Advertisement
Advertisement